Purpose The high flow nasal cannula (HFNC) has recently been proposed to support infants
with respiratory syncytial virus (RSV)-related respiratory distress. However, in this disease …

Purpose High-flow nasal cannula (HFNC) therapy is increasingly proposed as first-line
respiratory support for infants with acute viral bronchiolitis (AVB). Most teams use 2 L/kg/min …

High-flow nasal cannula (HFNC) is a relatively new device for respiratory support. In
pediatrics, HFNC use continues to increase as the system is easily set up and is well …

Background High flow nasal cannula (HFNC) systems utilize higher gas flow rates than
standard nasal cannulae. The use of HFNC as a respiratory support modality is increasing in …

The main physiological impact of high flow nasal cannula (HFNC) therapy is presumed to be
a decrease in work of breathing (WOB). To assess this, diaphragmatic electrical activity and …

Purpose Nasal continuous positive airway pressure (nCPAP) is currently the gold standard
for respiratory support for moderate to severe acute viral bronchiolitis (AVB). Although …

Objectives: Viral bronchiolitis is an acute infection and inflammatory disease of the
respiratory tract, with infants typically presenting with the most severe symptoms. Medical …

Continuous positive airway pressure (CPAP) has been used in infants with bronchiolitis for
decades. Recently, high flow nasal cannula (HFNC) therapy was introduced. We conducted …

OBJECTIVES: To determine whether the introduction of heated humidified high-flow nasal
cannulae (HFNC) therapy was associated with decreased rates of intubation for infants< 24 …

Background Viral bronchiolitis is the leading cause of hospitalization in children during the
first 12 months of life. There is evidence to support the use of noninvasive ventilation in …